Manager × security

Vident Advisory, LLC UNH holdings history

Who else holds this security? →

UNITEDHEALTH GROUP INC · CUSIP 91324P102 · CIK 1744347

Citable facts

As of 2026-06-30, Vident Advisory, LLC reported 154.99K UNH (shares), valued at $64.42M, or 0.48% of its reported non-derivative portfolio. Filed 2026-08-12.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.48%
Shares
154.99K
154,986
Reported value
$64.42M
USD

Shares increased 0.52%; reported value increased 54.40%, and weight changed +0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.48%154,986SEC filing ↗Filed Aug 12, 2026Combination report
Q1 20260.36%154,186SEC filing ↗Filed May 15, 2026Combination report
Q4 20250.44%141,437SEC filing ↗Filed Feb 18, 2026Combination report
Q3 20250.45%133,318SEC filing ↗Filed Nov 14, 2025Combination report
Q2 20250.44%126,845SEC filing ↗Filed Aug 14, 2025Combination report
Q1 20250.68%88,866SEC filing ↗Filed May 15, 2025Combination report
Q4 20240.72%81,032SEC filing ↗Filed Feb 14, 2025Combination report
Q3 20240.18%12,496SEC filing ↗Filed Nov 14, 2024Combination report
Q2 20240.50%35,490SEC filing ↗Filed Aug 14, 2024Combination report
Q1 20241.47%142,410SEC filing ↗Filed May 14, 2024Combination report
Q4 20231.44%108,829SEC filing ↗Filed Feb 14, 2024Combination report
Q3 20231.59%101,588SEC filing ↗Filed Feb 21, 2024AmendedCombination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.59%101,588$51.22MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Feb 21, 2024
Q4 20231.44%108,829$57.30MShares increased 7.13%; reported value increased 11.86%, and weight changed -0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20241.47%142,410$70.45MShares increased 30.86%; reported value increased 22.96%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20240.50%35,490$18.07MShares decreased 75.08%; reported value decreased 74.35%, and weight changed -0.97 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20240.18%12,496$7.31MShares decreased 64.79%; reported value decreased 59.57%, and weight changed -0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20240.72%81,032$40.99MShares increased 548.46%; reported value increased 461.00%, and weight changed +0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20250.68%88,866$46.54MShares increased 9.67%; reported value increased 13.55%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20250.44%126,845$39.57MShares increased 42.74%; reported value decreased 14.98%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20250.45%133,318$46.03MShares increased 5.10%; reported value increased 16.33%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20250.44%141,437$46.69MShares increased 6.09%; reported value increased 1.42%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 18, 2026
Q1 20260.36%154,186$41.72MShares increased 9.01%; reported value decreased 10.64%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20260.48%154,986$64.42MShares increased 0.52%; reported value increased 54.40%, and weight changed +0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2026
Vident Advisory, LLC · UNITEDHEALTH GROUP INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1744347","quarter":"2026Q2","cusip":"91324P102"}

get_institutional_manager_history
{"cik":"1744347","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.